How the diversified business model of Catalent, Inc (XNYS:CTLT) provides a safe investment opportunity?

How the diversified business model of Catalent, Inc (XNYS:CTLT) provides a safe investment opportunity?

ByMarketFacts

Catalent, Inc. (NYSE: CTLT) is a leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, gene therapies, and consumer health products. Operating as a Contract Development and Manufacturing organization (CDMO), the company serves a wide range of customers in the pharmaceutical, biotech, and consumer health industries.
It operates under four main segments: biologics, softgel and oral technologies, oral and specialty delivery, and clinical supply services. The company is known for its expertise in developing and manufacturing complex and difficult-to-formulate products, and for its ability to rapidly scale up production to meet the needs of its customers.

What makes Hannon Armstrong (XNYS:HASI) a textbook buy stock?

What makes Hannon Armstrong (XNYS:HASI) a textbook buy stock?

ByMarketFacts

Hannon Armstrong Sustainable Infrastructure Capital Inc (XNYS: HASI) finances the US energy markets using debt and equity. The company’s investments are divided into energy-efficiency initiatives and renewable-energy projects. Energy-efficiency initiatives lower the energy usage and expense of a building or facility by improving or installing building components such as heating, ventilation, and air conditioning systems, lighting, energy controls, roofs, windows, building shells, and heat and power systems. Renewable-energy projects use greener energy sources like solar and wind to create electricity. The organization also offers finance for other initiatives to improve energy efficiency and the environment. 

Is Protagonist Therapeutics Inc. (NASDAQ: PTGX) a good buy from biotechnology Industry?

Is Protagonist Therapeutics Inc. (NASDAQ: PTGX) a good buy from biotechnology Industry?

ByMarketFacts

Protagonist Therapeutics, Inc.(XNAS:PGTX) is a biopharmaceutical company that discovers and develops peptide based therapeutic drugs to address hematology and blood disorders, as well as inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with polycythemia vera and hereditary hemochromatosis, as well as for the treatment of other blood disorders; PN-943, an oral, alpha-4-beta-7 antagonist peptide, which is currently in Phase II clinical trials for the treatment of inflammatory bowel disease (IBD); and PN-235, an interleukin-23 receptor antagonist for the treatment of both IBD and non-IBD indications. A license and collaboration agreement has been signed between the company and Janssen Biotech Inc.

Is ESI a good opportunity for investors seeking growth: Element Solutions Inc (NYSE: ESI)?

Is ESI a good opportunity for investors seeking growth: Element Solutions Inc (NYSE: ESI)?

ByMarketFacts

Element Solutions Inc. (XYNS: ESI) is a global diversified specialty chemicals company focused on providing innovative solutions across several large and growing end-markets that enhance the products of everyday life. Developed in multi-step technological processes, the company’s innovative solutions enable the customers’ manufacturing processes in several key segments, including electronic circuitry, communication infrastructure, automotive systems, industrial surface finishing, consumer packaging, and offshore energy. With a long-standing presence in automotive markets and a deep market expertise in electronics, it sits at the intersection of this fast-growing market.

Will Plug power up your portfolio?
|

Will Plug power up your portfolio?

ByMarketFacts

Plug Power Inc. (NASDAQ:PLUG) is an American company engaged in the development of hydrogen fuel cell systems that replace conventional batteries in equipment and vehicles powered by electricity. As the leading provider of comprehensive hydrogen fuel cell (HFC) turnkey solutions, Plug is constructing the hydrogen economy. In the midst of a persistent paradigm shift in the power, energy, and transportation sectors to address climate change and energy security, while delivering efficiency benefits and meeting sustainability targets, the company’s breakthrough technology powers electric motors using hydrogen fuel cells. The company is the largest purchaser of liquid hydrogen and has installed more than 50,000 fuel cell units and over 165 fuelling stations, more than any other company in the world, to establish the first commercially viable market for hydrogen fuel cell technology.

Are Novavax’s protein technology Covid shots & omicron-fighting prototype worth Investing : Novavax, Inc. (NASDAQ: NVAX) ?

Are Novavax’s protein technology Covid shots & omicron-fighting prototype worth Investing : Novavax, Inc. (NASDAQ: NVAX) ?

ByMarketFacts

Novavax, Inc (NASDAQ: NVAX) is a biotechnology company committed to help address serious infectious disease globally through the discovery, development, and delivery of innovative vaccines to patients around the world. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. Prior to 2020, company developed experimental vaccines for influenza and respiratory syncytial virus, as well as Ebola and other emerging infectious diseases.

Is Marathon Digital Holdings A Buy As Bitcoin Slumps?

Is Marathon Digital Holdings A Buy As Bitcoin Slumps?

ByMarketFacts

Marathon Digital Holdings, Inc. (NASDAQ: MARA) Focuses on mining cryptocurrencies and generation of digital assets. The Company currently operates in the Digital Currency Blockchain segment and owns crypto-currency mining machines and a data centre to mine digital assets. Marathon Digital Holdings aims to build the largest mining operation in North America at one of the lowest energy costs.

Why Snap Stock Is a Buy Ahead of Earnings ?
|

Why Snap Stock Is a Buy Ahead of Earnings ?

ByMarketFacts

Snap Inc. (NYSE: SNAP) is an American camera and social media company. The company develops and maintains technological products and services, such as the image messaging and multimedia mobile app Snapchat and the personal emoji Bitmoji. It also develops and manufactures the wearable camera called Spectacles. The firm has approximately 158 million daily active users. Snap generates nearly all of its revenue from advertising with 88% coming from the U.S.

Shall you invest in this Renewable Solar Energy Company: Array Technologies Inc.(NASDAQ: ARRY)?
|

Shall you invest in this Renewable Solar Energy Company: Array Technologies Inc.(NASDAQ: ARRY)?

ByMarketFacts

Array Technologies Inc. (NASDAQ: ARRY) is a manufacturer of ground-mounting systems used in Solar Energy Projects. The company’s product is an integrated system of steel supports, electric motors, gearboxes, and electronic controllers referred to as a single-axis tracker that move solar panels throughout the day to maintain an optimal orientation to the sun, which increases their energy production. Its operations are in the United States, Australia, and Rest of the World with the United States deriving most of the revenue.